Evidence map›Paper›PMID 33505506›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2021

Secondary Metabolites, Antioxidant, and Antiproliferative Activities of

Muhammad Murtala Mainasara, Mohd Fadzelly Abu Bakar, Abdah Md Akim, Alona C Linatoc, Fazleen Izzany Abu Bakar, Yazan K H Ranneh

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 22 citations in OpenAlex.

  1. Bioactive Metabolites ofFoods (Basel, Switzerland) · 2025
    Review
  2. Drug design, development and therapy · 2025
    Review
  3. Molecules (Basel, Switzerland) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Muhammad Murtala MainasaraFaculty of Applied Sciences & Technology, Universiti Tun Hussein Onn Malaysia (UTHM), Hab Pendidikan Tinggi Pagoh, KM1, Jalan Panchor, Muar 84600, Johor, Malaysia.ORCID https://orcid.org/0000-0002-0105-6394
Mohd Fadzelly Abu BakarFaculty of Applied Sciences & Technology, Universiti Tun Hussein Onn Malaysia (UTHM), Hab Pendidikan Tinggi Pagoh, KM1, Jalan Panchor, Muar 84600, Johor, Malaysia.ORCID https://orcid.org/0000-0002-3589-9533
Abdah Md AkimDepartment of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Seri Kembangan 43400, Selangor, Malaysia.ORCID https://orcid.org/0000-0001-5989-5804
Alona C LinatocFaculty of Applied Sciences & Technology, Universiti Tun Hussein Onn Malaysia (UTHM), Hab Pendidikan Tinggi Pagoh, KM1, Jalan Panchor, Muar 84600, Johor, Malaysia.ORCID https://orcid.org/0000-0002-3565-0105
Fazleen Izzany Abu BakarFaculty of Applied Sciences & Technology, Universiti Tun Hussein Onn Malaysia (UTHM), Hab Pendidikan Tinggi Pagoh, KM1, Jalan Panchor, Muar 84600, Johor, Malaysia.ORCID https://orcid.org/0000-0001-5366-0991
Yazan K H RannehFaculty of Applied Sciences & Technology, Universiti Tun Hussein Onn Malaysia (UTHM), Hab Pendidikan Tinggi Pagoh, KM1, Jalan Panchor, Muar 84600, Johor, Malaysia.ORCID https://orcid.org/0000-0001-9916-8468
Tun Hussein Onn University of Malaysia · MYUniversiti Putra Malaysia · MYUsmanu Danfodiyo University · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is among the most commonly diagnosed cancer and the leading cause of cancer-related death among women globally. Malaysia is a country that is rich in medicinal plant species. Hence, this research aims to explore the secondary metabolites, antioxidant, and antiproliferative activities of

Identifiers

PMID33505506
PMCPMC7814937
OpenAlexW3118789753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.